Watch introductory animation
Did you know that point-of-care testing in the primary care office may increase HbA1c and uACR test adherence, leading to improved outcomes for patients with diabetes and kidney disease?1,2,3
Consider these critical factors:
- Guidelines call for routine testing of HbA1c and uACR for disease monitoring and management.4,5
- However, guideline recommended test adherence is reported at only about 70% for HbA1c, and 32% for uACR, in US adults with diabetes.4,6
- Research shows adoption of in-office testing can improve test adherence, improve practice efficiency and is cost-effective 1, 5, 6
Crocker JB, et al. The impact of point-of-care hemoglobin A1c testing on population health-based onsite testing adherence: a primary-care quality improvement study. J Diabetes Sc Technol. 2021;15(3):561-7. doi: 10.1177/1932296820972751
Schultes B, Emmerich S, Kistler AD, Mecheri B, Schnell O, Rudofsky G. Impact of Albumin-to-Creatinine Ratio Point-of-Care Testing on the Diagnosis and Management of Diabetic Kidney Disease. Journal of Diabetes Science and Technology. October 2021. doi:10.1177/19322968211054520
Crocker JB, Lee-Lewandrowsky E, Lewandrowsky N, et al. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014;142(5):640-646.
https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-G/part-493. Accessed 1/25/22.
Alfego, David et al. “Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence from a National Laboratory Database.” Diabetes care vol. 44,9 (2021): 2025-2032. doi:10.2337/dc21-0723
